NEVVI Medicare utilization intelligence

← back

ELRAFEI, TAREKD.O. NPI 1467563296 Clinician

Hematology-Oncology · BRONX, NY

Specialty Hematology-Oncology — from billed Medicare claims
In practice about 31 years since medical school (class of 1995, self-reported to CMS)
Location BRONX, NY · NPPES registered location
Active in data Billed Medicare 2020–2024 (5 consecutive years)
Scale 60 codes billed · 50,728 disclosed services (CY2024 — most recent year in data)
Current groups

Group affiliation since 2019

20192026
NORTH SHORE HEMATOLOGY ONCOLOGY ASSOCIATES PC
2019–2026

The roster archive begins in 2019, so a span starting at 2019 may reach back further. Membership spans only — no volume is attributed to any group here.

NPPES registry · CMS Doctors & Clinicians registry · Medicare Part B physician/supplier claims · NPPES record last updated 2007-08

Year: 2024 · 2023 · 2022  · 2021  · 2020 

Provider overview · all codes · CY2024

The full analytics for this provider

Premium

The billed-volume positioning, practice focus, and economics behind this provider — computed on the same disclosed Medicare Part B data.

This provider's disclosed Medicare payments across all codes were in CY2024. Unlock to see the figure.

  • Payment, service & beneficiary totals — the disclosed scale, all codes
  • Practice profile — focus & reach — top codes by share of services
  • Office vs. facility setting mix — place-of-service code split
  • Volume over five years — discrete yearly counts, no rate
  • Peer positioning — service volume — percentile among specialty peers, cohort & year disclosed
  • Peer positioning — code breadth — how many codes billed, vs peers

Peer positioning shows billed-volume and code-breadth positions among specialty peers, not measures of care (a provider's true volume position can only be higher, never lower). All figures disclosed Medicare Part B fee-for-service; volumes are personal to this NPI, not attributed to any group.

Notify me at launch → Or see a live example profile →

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
J1439 Injection, ferric carboxymaltose, 1 mg
88185 Flow cytometry technique for dna or cell analysis, each additional marker
36415 Insertion of needle into vein for collection of blood sample
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count
80053 Blood test, comprehensive group of blood chemicals
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
J1100 Injection, dexamethasone sodium phosphate, 1 mg
84100 Phosphate level
83615 Lactate dehydrogenase (enzyme) level
83735 Magnesium level
84550 Uric acid level, blood
82784 Gammaglobulin (immune system protein) measurement
82728 Ferritin (blood protein) level
83540 Iron level
83550 Iron binding capacity
99490 Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month
83521 Measurement of immunoglobulin light chains
82607 Cyanocobalamin (vitamin b-12) level
85044 Red blood count, manual test
82378 Carcinoembryonic antigen (cea) protein level
82746 Folic acid level, serum
84165 Protein measurement, serum
96372 Injection of drug or substance under skin or into muscle
86334 Immunologic analysis technique on serum (immunofixation)
88184 Flow cytometry technique for dna or cell analysis, first marker
85651 Red blood cell sedimentation rate, to detect inflammation, non-automated
82232 Beta-2 microglobulin (protein) level
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
84443 Blood test, thyroid stimulating hormone (tsh)
96413 Administration of chemotherapy into vein, 1 hour or less
82785 Ige (immune system protein) level
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less
99215 Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
86141 Measurement c-reactive protein for detection of infection or inflammation, high sensitivity
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes
84153 Psa (prostate specific antigen) measurement, total
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
J1200 Injection, diphenhydramine hcl, up to 50 mg
96374 Injection of drug or substance into vein
96375 Injection of additional new drug or substance into vein
85610 Blood test, clotting time
86300 Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3
83010 Haptoglobin (serum protein) level
96361 Infusion into a vein for hydration, each additional hour
82306 Vitamin d-3 level
84403 Testosterone (hormone) level, total
82668 Erythropoietin (protein) level
86304 Immunologic analysis for detection of tumor antigen, quantitative; ca 125
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
82533 Cortisol (hormone) measurement, total
80074 Acute hepatitis panel
81002 Urinalysis, manual test
85730 Coagulation assessment blood test, plasma or whole blood
82248 Bilirubin level, direct
86038 Screening test for autoimmune disorder
86431 Rheumatoid factor level
83036 Hemoglobin a1c level
99205 New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more
86301 Immunologic analysis for detection of tumor antigen, quantitative; ca 19-9
84436 Thyroxine (thyroid chemical), total

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.